Chemical Compound

Cladribine

CAS Registry Number 4291-63-8
Back to search Request a Quote
Cladribine chemical structure
Primary Record

Cladribine

In stock
5,277 g
Purity
98.3 %
CAS
4291-63-8

Compound Identifiers & Properties

CAS
4291-63-8
PubChem CID
20279
SMILES
C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O
Canonical SMILES
Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1

Names & Synonyms

  • Cladribine
  • 2-Chloro-2'-deoxyadenosine
  • Leustatin
  • 2-Chlorodeoxyadenosine
  • 4291-63-8
  • Litak
  • Cladarabine
  • cladribina
  • mavenclad
  • Chlorodeoxyadenosine
  • CldAdo
  • Cladaribine
  • 2-CdA
  • cladribinum
  • Movectro
  • Leustat
  • Mylinax
  • 2ClAdo
  • Cladiribine
  • Cladrivine
  • Leustatine
  • Leustatin (TN)
  • 2-chloro-deoxyadenosine
  • Cladribine CRS
  • 2-Chloro-2'-deoxy-beta-adenosine
  • Mavenclad (TN)
  • 2 Chlorodeoxyadenosine
  • ADENOSINE, 2-CHLORO-2'-DEOXY-
  • 2CdA
  • Cladribine (Standard)
  • 2'-Deoxy-2-chloroadenosine
  • C10H12ClN5O3
  • CLADRIBINE [MI]
  • DTXSID8022828
  • Cladribine [USAN:INN:BAN]
  • RWJ 26251
  • AC1L2FXP
  • CLADRIBINE [INN]
  • CLADRIBINE [JAN]
  • Opera_ID_1191
  • RefChem:388887
  • CLADRIBINE [HSDB]
  • CLADRIBINE [USAN]
  • MLS000028377
  • CLADRIBINE [VANDF]
  • MFCD00153939
  • RWJ-26251
  • 2-Chloro-2-deoxyadenosine
  • D05GJW
  • UNII-47M74X9YT5
  • CLADRIBINE [MART.]
  • SCHEMBL3775
  • CCRIS 9374
  • DTXCID602828
  • PTOAARAWEBMLNO-KVQBGUIXSA-N
  • 47M74X9YT5
  • Adenosine, 2-chloro-2'-deoxy
  • CHEMBL1619
  • CLADRIBINE [USP-RS]
  • CLADRIBINE [WHO-DD]
  • Cladribine (JAN/USP/INN)
  • 2-chloro-2'-deoxy-adenosine
  • cid_20279
  • HSDB 7564
  • MLS000028484
  • MLS000759397
  • MLS001077345
  • MLS001424194
  • Cladribine (JAN/USAN/INN)
  • CLADRIBINE [EMA EPAR]
  • Cladribine [USAN:BAN:INN]
  • NSC-105014
  • CHEBI:567361
  • NSC 105014-F
  • 2-Chloro-2 -deoxyadenosine
  • Cladribine - Bio-X trade mark
  • Cladribine [USAN:USP:INN:BAN]
  • GTPL4799
  • orb1305319
  • 2-Chloro-2'-deoxy-D-adenosine
  • CLADRIBINE [ORANGE BOOK]
  • NSC 105014
  • SCHEMBL29355473
  • BDBM38920
  • C10H12ClN5O3.C3H8
  • CTK8D4033
  • BRN 0624220
  • CLADRIBINE [EP MONOGRAPH]
  • CLADRIBINE [USP IMPURITY]
  • L01BB04
  • L04AA40
  • Cladribine CRS (Y0000639)
  • Cladribine for peak identification
  • NSC105014
  • CLADRIBINE [USP MONOGRAPH]
  • GLXC-05407
  • HMS2052K13
  • HMS2232C23
  • HMS3715F17
  • SMR000058553
  • C10-H12-Cl-N5-O3
  • ACT02615
  • AMY22140
  • BCP02868
  • CID20279
  • NSC105014-F
  • ZINC3798064
  • Tox21_110834
  • Tox21_300596
  • CC0168
  • CID:20279
  • EBC-11113
  • HY-13599R
  • NSC-05014
  • NSC-105014-F
  • AKOS015854898
  • AKOS015892544
  • Cladribine for peak identification CRS
  • AC-7591
  • ACN-040521
  • BCP9000538
  • CCG-101116
  • CS-2057
  • DB00242
  • NC00366
  • NC06337
  • RTC-063884
  • RWJ-26251-000
  • NCGC00018167-03
  • NCGC00022567-05
  • NCGC00022567-06
  • NCGC00022567-07
  • NCGC00022567-08
  • NCGC00164384-01
  • NCGC00254518-01
  • 2-Chloro-2'-deoxyadenosine, antileukemic
  • AJ-45639
  • AS-12366
  • BC164318
  • BP-25407
  • BR-46529
  • CJ-10765
  • CPD000058553
  • HY-13599
  • LS-15109
  • SAM001246526
  • SC-17356
  • SID:57309572
  • SY059947
  • (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
  • CAS-4291-63-8
  • AB0011806
  • J446.344G
  • ST2409775
  • TC-063884
  • 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
  • 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine
  • A2187
  • NS00005088
  • S1199
  • SW197746-4
  • Leustatin, 2-chlorodeoxyadenosine, Cladribine
  • A10223
  • D01370
  • S-7479
  • (2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
  • 9-(2-Deoxy-b-D-ribofuranosyl)-2-chloroadenine
  • AB00382963-17
  • AB00382963_19
  • (2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
  • 291C638
  • A826062
  • D017338
  • F078689
  • Q414030
  • SR-01000003063
  • 2-Chloro-2 inverted exclamation mark -deoxyadenosine
  • SR-01000003063-7
  • 2-Chloro-2'-deoxyadenosine, 99% - 100MG 100mg
  • BRD-K93034159-001-25-8
  • SR-01000003063-10
  • B2693-004182
  • Cladribine, European Pharmacopoeia (EP) Reference Standard
  • 6-amino-2-chloro-9-(2-deoxy-beta-erythropentofuranosyl)purine
  • Cladribine, United States Pharmacopeia (USP) Reference Standard
  • (2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
  • 6-Amino-2-chloro-9-(2-deoxy-beta-D-arabinofuranosyl)-9H-purine
  • 6-amino-2-chloro-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
  • (2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxalan-3-ol
  • CL9
  • Cladribine for peak identification, European Pharmacopoeia (EP) Reference Standard
  • 24757-90-2
  • 5542-92-7
  • Cladribine; Adenosine, 2-chloro-2'-deoxy-; 2-Chloro-2'-deoxyadenosine; (2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2-CdA; 2-Chlorodeoxyadenosine; Biodribin; Cladarabine; CldAdo; Jk 6251; Leustat; Leustatin; NSC 105014; NSC 105014-F; RWJ 26251; 2-Chloro-9-(2-deoxy-beta-d-erythro-pentofuranosyl)-9H-purin-6-amine; 2-Chloro-2'-deoxy-beta-adenosine; 2-Chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
  • Leustatin|||2-Chloro-2'-deoxyadenosine|||2-CdA|||NSC-105014-F|||(2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol